Alcami Corporation, a pharmaceuticals company headquartered in North Carolina, is investing at least $5 million in the expansion of its existing operations in Charleston County, South Carolina.
This project is expected to lead to the creation of at least 30 new jobs.
Gov. Henry McMaster said they look forward to seeing the new heights the relationship between the state and the company will reach in the years to come.
“To see a company like Alcami choose to continue investing in our state and our people is an important sign to the business community around the world that South Carolina is the place to be,” said McMaster.
Alcami offers a variety of biopharmaceutical services across active pharmaceutical ingredients, drug products (sterile, oral solid dose, packaging and labeling), development services and analytical testing.
With six state-of-the-art locations in the United States and a seventh in the Netherlands, the company has supported more than 500 Investigational New Drug (IND) filings over the past 30 years.
Stephen Kutzer, Alcami CEO and president, said, “The Charleston facility is an integral part of the Alcami network. We are excited about the growth potential of the site and its ability to support the increased demand for sterile drug product development and manufacturing.”
Located at 4221 Faber Place Drive in North Charleston, S.C., Alcami will continue to expand its filling and freeze-drying capabilities.
The site has recently produced clinical supply from its recently-qualified second line and doubled both its filling capacity and freeze-drying capacity with increased scheduling flexibility, including a third operating shift.
Hiring for the new positions is already underway, and interested applicants should visit Alcami’s careers page online(link is external) for more information.